1.
Ebert KM, Posid T, Dall CP, Shah KK, Broutian T, Harbrecht MT, Hudson C, Hundley A, Scimeca A, Bellows FF. Promoting patient followup treatment with intra-detrusor onabotulinumtoxinA for overactive bladder. CUAJ [Internet]. 2021 Jan. 4 [cited 2024 Mar. 28];15(8):E405-11. Available from: https://cuaj.ca/index.php/journal/article/view/6983